IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Shree Ganesh Remedies Ltd.
Issue Open Date 28-Sep-17  
Issue Closing Date 05-Oct-17  
Application Money 100  
Allotment Money  
Price Band 36 -  
Minimium Application No. 3000  
Issue Size (Shares) 2376000  
Market Lot 1.00  
Objective
OBJECTS OF THE ISSUEThe Issue comprises of fresh issue of 23,76,000 Equity Shares by our Company aggregating up to Rs.855.36 Lakhs (“Fresh Issue”).Our Company proposes to utilize the Net Proceeds from the issue towards the following objects:1. Setting up a new Choloro Compound derivatives manufacturing plant with a proposed capacity of200 MTPA at Ankleshwar GIDC Gujarat (“Project”);2. General Corporate Purposes
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors       NA  
Qualified Institutional Buyers       NA  
Retail Individual Investors       NA  
Business Description
OVERVIEWOur Company was originally incorporated as “Shree Ganesh Remedies Private Limited” at Ahmedabad,Gujarat as a Private Limited Company under the provisions of Companies Act, 1956 vide Certificate ofIncorporation dated April 27, 1995 bearing registration
more...
Promoter's Holding
Total Share Capital   5626398  
Offered to Public   2376000  
Promoter's Holding (Pre-Issue)   85.31  
Promoter's Holding (Post-Issue)   62.72  
Address
Plot No. 6002
6003
6011 & 6012
G. I. D. C.
Bharuch
Ankleshwar ,
Gujarat ,
393002
Phone: 07574 976076
Email: investors@ganeshremedies.com
Website: www.ganeshremedies.com
Registrar
Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village
Opp: Yashoda Hospital
Raj Bhavan Road
Somajiguda
Hyderabad
Listed at
BSE
Lead Manager
Fedex Securities Ltd.
Promoters
Ashokkumar Kothia
Babubhai Kothia
Chandubhai Kothia
Hansaben Kothia
Hasmukh Kothia
Manubhai Kothia
Subhash Kothia
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.